Malaysia in final stage of talks with Covid-19 vaccine manufacturers

Through Covax, Malaysia will obtain enough vaccine for 10 per cent of the population.- Reuters

KUALA LUMPUR (Bloomberg): Malaysia has contacted ten manufacturers whose coronavirus vaccines are at Phase 3 of the clinical trials, said Science, Technology and Innovation Minister Khairy Jamaluddin in Parliament on Monday (Nov 16).

He said several negotiations have reached the final stage and an agreement will be reached soon.

The talks cover cooperation in various stages of vaccine development such as R&D, exchange of scientists, development of fill and finish (technology transfer, logistics, cold chain), and purchase of vaccines.

Through Covax, Malaysia will obtain enough vaccine for 10 per cent of the population. The government is working on obtaining another 60 per cent to enable herd immunity in the country.

It is also working on getting access to the vaccines as early as the first or second quarter of next year.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Did you find this article insightful?


73% readers found this article insightful

Next In Aseanplus News

China's Greater Bay Area seen as 'test bed' for new ideas, designs
Abu Sayyaf member dies in shootout with cops in Zamboanga
Shanghai subways ban use of speakers on phones and digital devices
EU sets up online customs transit system to boost Asean trade
Japan Nike ad on bullying, racism sparks hot online response
Myanmar's University of Yangon holds virtual centennial celebration amid Covid-19
Xiaomi trade halted in Hong Kong by disclosure delay
European Union and Asean to form strategic partnership: Germany
Cambodia's Angkor Wat sees 80 per cent drop in foreign visitors in 11 months
From hijabs to cosplay, Indonesian finds calling in cat fashion makeovers

Stories You'll Enjoy